Hochrein SM, Wu H, Eckstein M, Arrigoni L, Herman JS, Schumacher F et al (2022) The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming
Diet Type
4 Discussion Current evidence strongly supports the efficacy of GLP-1 receptor agonists for inducing substantial weight loss, improving metabolic control, and reducing cardiovascular risk often surpassing the short-term effects of exercise alone ( Exercise and lifestyle interventions, while generally less potent for weight loss, provide unique and irreplaceable health benefits preserving skeletal muscle, improving cardiorespiratory fitness, enhancing psychological well-being, and lowering chronic disease risk ( Hybrid care models that integrate pharmacotherapy with behavioral support are emerging as the most promising framework for sustainable obesity and diabetes management ( Persistent challenges include the high cost and limited accessibility of GLP-1RAs, variable long-term adherence, and a lack of long-term data on sustainability, relapse rates, and overall health outcomes

Citicoline Citicoline (cytidine diphosphate choline) is not just a source of choline, the main building block of the neurotransmitter acetylcholine
Pairing it with Vitamin C improves absorption and helps recycle glutathione in the body
M., Li, X., Zhang, H